Keeping Track: Telework Kept FDA On Track During Blizzard
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Deal Watch: GSK Furthers Cancer Gene Therapy Plans Via Lyell Collaboration
GSK hopes the San Francisco biotech’s technology can help its cell therapy pipeline address solid tumors. Avacta partners with ADC on antibody-drug conjugates.
Keeping Track: Four Novel Agents Clear FDA; Two Complete Response Letters Issued
The latest drug development news and highlights from our FDA Performance Tracker.
Merck’s Bezlotoxumab C. Difficile Data Pave Way For Antibodies
Company readies regulatory filings for bezlotoxumab as a monotherapy in preventing C. difficile, following presentation of positive MODIFY I and II data at the ICAAC meeting in San Diego.